Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
EXAGEN INC. (XGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Exagen Inc. Reports Strong Second Quarter 2023 Results"
07/24/2023 8-K Quarterly results
05/04/2023 8-K Quarterly results
03/23/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/20/2023 8-K Quarterly results
01/23/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and ...
Docs: "AMENDMENT TO THE AMENDED AND RESTATED BYLAWS OF",
"Exagen Inc. Elects Tina S. Nova, Ph.D."
01/09/2023 8-K Quarterly results
12/05/2022 8-K Quarterly results
11/14/2022 8-K Quarterly results
Docs: "Exagen Inc. Reports Third Quarter 2022 Results"
10/20/2022 8-K Quarterly results
09/15/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "EXAGEN INC. $50,000,000",
"BOSTON LONDON LOS ANGELES NEW YORK SAN DIEGO SAN FRANCISCO WASHINGTON"
08/04/2022 8-K Quarterly results
Docs: "Exagen Inc. Reports Second Quarter 2022 Results"
06/21/2022 8-K Quarterly results
05/11/2022 8-K Quarterly results
04/28/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "EXAGEN INC. AMENDED AND RESTATED"
03/22/2022 8-K Quarterly results
Docs: "Exagen Inc. Reports Fourth Quarter and Full Year 2021 Results"
01/10/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "E CD3 CD20 CD68 CD138"
11/10/2021 8-K Quarterly results
10/25/2021 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Exagen Inc. Announces $27.2 Million Debt Refinancing"
10/19/2021 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
08/27/2021 8-K Quarterly results
08/09/2021 8-K Quarterly results
07/30/2021 8-K Quarterly results
06/21/2021 8-K Quarterly results
05/11/2021 8-K Quarterly results
03/23/2021 8-K Quarterly results
03/22/2021 8-K Quarterly results
03/16/2021 8-K Quarterly results
01/11/2021 8-K Quarterly results
12/28/2020 8-K Entry into a Material Definitive Agreement
11/10/2020 8-K Quarterly results
Docs: "Exagen Inc. Reports Third Quarter 2020 Results"
09/23/2020 8-K Quarterly results
07/28/2020 8-K Quarterly results
06/29/2020 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy